Poxel - Pharmaceutical Company set-up to find innovative solutions for metabolic diseases management with a primary focus on type 2 diabetes
About us
Our vision
Business model
Management
Board of Directors
Investors
Pipeline
Scientific Advisory Board
Academic Collaborations
Imeglimin
AMPK
GLP-1
Markets
Diabetes market
A market ready for innovation
Industry partnering
News
Press releases
Media coverage
Scientific publications
Calendar of events
Contact
Send a message
Map
Sitemap
Home
About us
Our vision
Business model
Management
Board of Directors
Investors
Pipeline
Scientific Advisory board
Academic Collaborations
Imeglimin
AMPK
GLP-1
Markets
Diabetes market
A market ready for innovation
Industry partnering
News
Press releases
Media coverage
Scientific publications
Calendar of events
Contact
Message
Map
Sitemap
|
Legal
© Poxel SA
